MD Anderson Cancer Center partners with GlaxoSmithKline

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers.

June 27, 2025

By Ghulam Rasool, Brian D. Gonzalez and Katherine Chung-Bridges

Cancer Policy

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

Jacqueline Corrigan-Curay, the acting director of the Center for Drug Evaluation and Research wrote in an email to colleagues that she will be retiring from the agency in July.

June 27, 2025

By Claire Marie Porter

Cancer Policy

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

Sen. Bill Cassidy (R-LA), a key Senate health leader, June 23 called for the meeting of the Advisory Committee on Immunization Practices to be delayed, citing concerns over the committee members’ lack of directly relevant experience and their potential bias against some vaccines.

June 27, 2025

By Claire Marie Porter and Jacquelyn Cobb

In Brief

Nicholas Jaidar named senior administrator for oncology at Johns Hopkins

Nicholas M. Jaidar was named senior administrator for oncology at the Department of Oncology at the Johns Hopkins University School of Medicine and the Johns Hopkins Hospital.

June 27, 2025

In Brief

Phyllis Harris appointed chief legal and risk officer at ACS

Phyllis Harris was appointed chief legal and risk officer of American Cancer Society, effective June 23.

June 27, 2025

In Brief

Multi-institutional team awarded $3.4M NCI grant to open AML trial

The University of Cincinnati Cancer Center, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Jabez Biosciences are partnering to open a new phase I clinical trial studying JBZ-001, a potential new treatment for acute myeloid leukemia.

June 27, 2025

MD Anderson Cancer Center partners with GlaxoSmithKline

YOU MAY BE INTERESTED IN

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

Nicholas Jaidar named senior administrator for oncology at Johns Hopkins

Phyllis Harris appointed chief legal and risk officer at ACS

Multi-institutional team awarded $3.4M NCI grant to open AML trial

Renew today!

Subscriber content

Never miss an issue!

Login